Overview The Federal Circuit upheld the US District Court for the District of Delaware’s decision that generic Slayback Pharma did not infringe Eagle Pharmaceutical’s patents covering its anti-cancer ...
Even when certain elements in a claimed method are not expressly disclosed in the prior art, the claim can still be held obvious if the missing elements are supplied in the form of an inherent propert...
There is always a danger in raising an argument for the first time on appeal. The Federal Circuit’s recent decision in Boston Scientific Neuromodulation v. Nevro (No. 2019-1584) provides yet another e...
An article written by Amanda Slade and John Strand titled "Supreme Court’s Booking.com Ruling Signals Uptick in Registration of ‘Generic.com’ Marks" was published in IPWatchdog. Read more.
An article written by Greg Corbett and Marie McKiernan titled "Impact and 'Unintended Benefits' of the Federal Circuit's Suspension of In-Person Oral Arguments" was published in Law.com. Read more (su...
An article written by Jonathan Roses and Toby Simpson, partner at Hoffmann Eitle, titled “The intersection of regulatory and patent exclusivities for the life sciences industry: a comparative overview...
In spite of social distancing requirements established by the COVID-19 pandemic, courts are now more likely to expect that litigants have been diligently keeping up with various pretrial tasks. While ...
A stay is an important mechanism for many defendants to consider when filing an IPR. Due to the ongoing pandemic, courts have had to shift resources to address COVID-19-related concerns. In some insta...
UPDATE: THE FOLLOWING CONTENT WAS ADDED JUNE 1, 2020 On May 27, 2020, the Honorable Colleen McMahon issued trial procedures in Ferring Pharmaceuticals Inc., et al. v. Serenity Pharmaceuticals, LLC, et...
An article co-authored by Hunter Keeton titled “Divided Infringements Still Dividing Courts? New Cases Provide More Insights” was published by Westlaw Journal. Read more.
Recent orders by the Honorable Rodney Gilstrap in the Eastern District of Texas demonstrate the potential impact of foreign discovery during the pandemic. In Canon, Inc. v. TCL Electronics Holdings Lt...
Invalidity grounds in IPR that are not based on patents must be based on printed publications. But the nature of the evidence required at the time of institution to show that a non-patent reference is...